Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow
NCT06301880Phase 3Completed
- Sponsor
- Damascus University
- Start
- Jan 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milrinone, nitroglycerin in internal mammary artery syndrome, sponsored by Damascus University. Started Jan 2022; status: completed.
02
Drugs
milrinonenitroglycerin
03
Conditions
internal mammary artery syndrome
Beyond the preview
Go deeper on NCT06301880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06301880.